The contribution of reticulocytes and other young RBC toward both the hemolytic and vasocclusive aspects of sickle cells disease has become more apparent in recent years. At the same time, effective treatment strategies (hydroxyurea) and promising experimental agents (clotrimazole) have become available. These agents induce fundamental but poorly understood changes in the behavior of sickle cells. In the proposed research, studies will be performed to better understand the time-dependent cellular changes that occur in circulating sickle cells, the role of cell age and HbF content in determining these changes, and the modification of sickle cell behavior that occurs as a result of effective treatment. Three types of experiments will be performed: 1) Detailed in vitro analysis of RBC subpopulations in density fractions. These experiments will shed light on the extent of dehydration as a function of age and HbF content, and on changes in the behavior of these cellular subtypes with treatment; 2) Investigations of the transport pathways that lead to dehydration of young and mature RBC under oxy and deoxy conditions, and the changes in the activity of these pathways with treatment; 3) In vivo, multiparametric tracking of biotin- labeled, autologous sickle cells to determine the survival and time- dependent hydration change of RBC subtypes, the influence of cell age and HbF, and the changes that occur after effective treatment. The observed red cell behavior, before and after treatment, will be analyzed in the context of a comprehensive model of sickle cell dehydration and survival. In this model, initial reticulocyte dehydration is dependent on the activity of the CI co-transport pathway for K efflux and is independent of deoxygenation and HbF, while terminal stages of dehydration are sickling dependent, with HbF playing an important role. These investigations will provide a better understanding of sickle cell pathophysiology, define the cellular changes that occur as a result of effective treatment, and provide the information necessary to formulate improved treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL058421-05
Application #
6584667
Study Section
Project Start
2002-04-01
Project End
2003-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
5
Fiscal Year
2002
Total Cost
$228,564
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Crosby, Lori E; Modi, Avani C; Lemanek, Kathleen L et al. (2009) Perceived barriers to clinic appointments for adolescents with sickle cell disease. J Pediatr Hematol Oncol 31:571-6
Crable, Scott C; Hammond, Suzan M; Papes, Richard et al. (2005) Multiple isoforms of the KC1 cotransporter are expressed in sickle and normal erythroid cells. Exp Hematol 33:624-31
Zhou, Guo-Ping; Wong, Clara; Su, Robert et al. (2004) Human potassium chloride cotransporter 1 (SLC12A4) promoter is regulated by AP-2 and contains a functional downstream promoter element. Blood 103:4302-9
Yasin, Zahida; Witting, Scott; Palascak, Mary B et al. (2003) Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 102:365-70
Merciris, P; Claussen, W J; Joiner, C H et al. (2003) Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells. Pflugers Arch 446:232-8
Holtzclaw, J David; Jiang, Maorong; Yasin, Zahida et al. (2002) Rehydration of high-density sickle erythrocytes in vitro. Blood 100:3017-25
Joiner, C H; Jiang, M; Claussen, W J et al. (2001) Dipyridamole inhibits sickling-induced cation fluxes in sickle red blood cells. Blood 97:3976-83
Joiner, C H; Franco, R S (2001) The activation of KCL cotransport by deoxygenation and its role in sickle cell dehydration. Blood Cells Mol Dis 27:158-64
Franco, R S; Yasin, Z; Lohmann, J M et al. (2000) The survival characteristics of dense sickle cells. Blood 96:3610-7